2-((3,5-dichloropyridin-4-yl)thio)-N-(3-((3-(dimethylamino)propyl)amino)-1,1-dioxido-2,3-dihydrobenzo[b]thiophen-6-yl)thiazole-5-carboxamide

ID: ALA5284905

Chembl Id: CHEMBL5284905

Max Phase: Preclinical

Molecular Formula: C22H23Cl2N5O3S3

Molecular Weight: 572.56

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCCNC1CS(=O)(=O)c2cc(NC(=O)c3cnc(Sc4c(Cl)cncc4Cl)s3)ccc21

Standard InChI:  InChI=1S/C22H23Cl2N5O3S3/c1-29(2)7-3-6-26-17-12-35(31,32)19-8-13(4-5-14(17)19)28-21(30)18-11-27-22(33-18)34-20-15(23)9-25-10-16(20)24/h4-5,8-11,17,26H,3,6-7,12H2,1-2H3,(H,28,30)

Standard InChI Key:  BKBKTPNBWVKIQI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5284905

    ---

Associated Targets(Human)

USP7 Tchem Ubiquitin carboxyl-terminal hydrolase 7 (837 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 572.56Molecular Weight (Monoisotopic): 571.0340AlogP: 4.62#Rotatable Bonds: 9
Polar Surface Area: 104.29Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.71CX Basic pKa: 8.04CX LogP: 3.24CX LogD: 2.50
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.36Np Likeness Score: -1.41

References

1. Li P, Liu HM..  (2020)  Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.,  191  [PMID:32092586] [10.1016/j.ejmech.2020.112107]

Source